Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by RevBio, Inc.

RevBio Expands Globally into the United Kingdom with its Second Cranial Flap Fixation Clinical Trial for its Regenerative Bone Adhesive
From RevBio, Inc.
Via Business Wire
RevBio Initiates its Pivotal Clinical Trial in Europe for its Dental Implant Stabilization Product
From RevBio, Inc.
Via Business Wire
RevBio Issued a Key Patent for its Regenerative Bone Adhesive Technology by the United States Patent and Trademark Office
From RevBio, Inc.
Via Business Wire
RevBio Receives Both FDA Approval to Expand its Clinical Trial and CMS Reimbursement for its Regenerative Bone Adhesive for Cranial Flap Fixation
From RevBio, Inc.
Via Business Wire
RevBio Receives FDA Approval to Conduct a First-in-Human Clinical Trial for its Regenerative Bone Adhesive for Cranial Flap Fixation
From RevBio, Inc.
Via Business Wire
RevBio Receives a $2.4 Million NIH Grant to Conduct a First-in-Human Clinical Trial for its Regenerative Bone Adhesive for Cranial Flap Fixation and Enrolls First Five Patients
From RevBio, Inc.
Via Business Wire
RevBio Awarded a $2 Million Follow-On NIH Grant to Reduce Opioid Use and Addiction with TETRANITE®
From RevBio, Inc.
Via Business Wire
RevBio Awarded a $3.4 Million NIH Grant for Its Novel Regenerative Bone Adhesive to Treat Complex Fractures
From RevBio, Inc.
Via Business Wire
RevBio Receives FDA Approval to Conduct its Second U.S.-Based Clinical Trial for Dental Implant Stabilization
From RevBio, Inc.
Via Business Wire
RevBio is Awarded a $2 Million Grant to Advance the Development of its Novel Dental Adhesive Bone Scaffold Product
From RevBio, Inc.
Via Business Wire
RevBio Receives ISO 13485 Certification for its Quality Management System
From RevBio, Inc.
Via Business Wire
RevBio Receives a Strategic Investment from Pacific Dental Services to Support Ongoing Clinical Trials in Implant Dentistry
From RevBio, Inc.
Via Business Wire
RevBio Receives Approval to Start a Dental Clinical Trial in Italy for its Regenerative Biomaterial
From RevBio, Inc.
Via Business Wire
RevBio Launches an Experiment for its Regenerative Biomaterial on the International Space Station
From RevBio, Inc.
Via Business Wire
RevBio Receives NIH Grant to Explore the Treatment of Vertebral Compression Fractures with Its Regenerative Bone Adhesive Technology
From RevBio, Inc.
Via Business Wire
RevBio Receives Approval from the U.K.’s Regulatory Authority to Initiate a Clinical Trial for an Optimized Formulation of its Dental Bone Adhesive Biomaterial
From RevBio, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.